Biopas – LATAM Licensing Interests

Biopas is seeking to secure partnerships with leading pharma and biotech companies to license the Latin American rights to already marketed or new innovative products

About Biopas

Biopas is a leading and differentiated Latin American pharmaceutical company, focused on in-licensing, marketing, and selling of cutting-edge specialty pharmaceutical products.

The company holds leading positions in CNS, Immunology, Dermatology, Oncology and Orphan Drugs and operates in all of LatAm with fully owned subsidiaries and more than 250 employees in Latin America.

Biopas is focused on innovative and differentiated products, offering multiple therapeutic options to specialists in niche indications that cover unmet medical needs of patients.

Biopas offers best in class capabilities in sales, marketing, medical, support functions and provides integral services to support the launch and development of products. All its functions operate in compliance with international standards and regulations.

One-Stop Solution Provider for all of Latin America

Biopas has developed a turnkey solution to accelerate growth of pharma companies in Latin America, as the “Partner of Choice” to launch and develop products in the region. Biopas is focused on de-risking these emerging markets territories, providing unmatched market access and revenue opportunities for its partners.

Biopas removes significant management disruption by eliminating complexity and time costs associated with doing business and closing deals on a country by country basis.


Biopas is committed to creating solid, faithful, long-term relationships with its partners to launch and commercialize new products in the Latin American region.

Biopas has a 20 year strong operating history with a proven track record of success with leading pharmaceutical partners (UCB, IPSEN, Ferring and Vertex among others) and is led by an experienced management team.

If you would like to partner with us,
please get in touch

Global Business Development Team